TELEO Capital Management announced it has acquired SmartFactory Rx, a pharmaceutical manufacturing intelligence platform, from Applied Materials. As part of the transaction, SmartFactory Rx has been rebranded as Modersys.
Modersys helps biopharmaceutical, nutritional, and other life sciences companies improve yield, reduce variability, accelerate time to market, and maintain regulatory fidelity. The platform combines real-time analytics, AI and machine learning process intelligence, advanced process control, adaptive scheduling, and alarm management across the full manufacturing lifecycle, from early-stage process development through GMP commercial production.
With more than 30 years of expertise and deployments across the U.S., Europe, and Asia Pacific, Modersys is used in demanding manufacturing environments across regulated industries. Across customer deployments, the platform has delivered measurable results, including yield improvements of up to 10%, throughput gains of up to 15%, reductions in experimental effort of up to 50%, and equipment availability gains of more than 22 days per plant per year.
Through TELEO’s investment, Modersys plans to accelerate platform innovation, enhance its AI capabilities, and deliver faster insights and more autonomous manufacturing outcomes for customers. As an independent company, Modersys will focus on biopharmaceutical, nutritional, and life sciences customers while pursuing organic and strategic growth initiatives to expand its global reach.
